Former FDA Generic Drug Division chief remains in intensive care at Nix Medical Center in San Antonio as of March 20. Seife was serving a 10-month sentence for making false statements to government investigators about meals with industry when he became seriously ill several weeks ago ("The Pink Sheet" March 16, T&G-1). He is in the custody of his brother. The Maryland U.S. Attorney's Office, which prosecuted the former FDAer, has yet to receive papers related to an expected Federal Bureau of Prisons request that Seife's sentence be commuted.
You may also be interested in...
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth